High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$28.4M
$28,377,385
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-25
$897,802
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-25 | $897,802 | S | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
Other
2026-02-19
$4,693,126Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
Other
|
2026-02-19 | $4,693,126Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$426,797
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $426,797 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$1,269,586Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $1,269,586Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$860,798
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $860,798 | S | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
Other
2026-02-19
$3,652,628Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
Other
|
2026-02-19 | $3,652,628Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -19.3%
2026-02-19
$9,213,023Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -19.3%
|
2026-02-19 | $9,213,023Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$3,400,446Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $3,400,446Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -15.6%
2026-02-19
$5,510,964Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -15.6%
|
2026-02-19 | $5,510,964Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$1,997,449Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $1,997,449Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$4,800,518Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $4,800,518Large | S | Form 4 |